1 recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
Follow Chemotherapy-intolerant: new trials by email Literature Review of Chemotherapy-intolerant trials Research Report on Chemotherapy-intolerant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer Fixed neoantigen tumor vaccine, personalized neoantigen tumor vaccine, PD-1 inhibitor - Pancreatic Cancer Resectable, Chemotherapy-intolerant | Early Phase 1 | Recruiting | Ruijin Hospital | 20 | 2024-07-16 | 2025-11-17 |
Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Pancreatic Diseases (1)
Immune Checkpoint Inhibitors (1)
Ruijin Hospital (1)
China (1)